We describe the broad range of uncertainties faced by the developers of medical technologies. Empirically, we estimate the asset market incidence of the realization  of two such of uncertainties experienced by the biotechnology firm Myriad Genetics, Inc.

We analyze the effects of the COVID-19 pandemic on state and local government finances, with an emphasis on health spending needs and the role of the Medicaid program. We arrive at three conclusions. First, we find that nationwide, and over the entirety of the federal budget window, the enhanced...

COVID-19 relief legislation offers a unique setting to study how political representation shapes the distribution of federal assistance to state and local governments. We provide evidence of a substantial small-state bias: an additional Senator or Representative per million residents predicts an...